QuiVad
My list

Home / Japan / Immuno-Biological Laboratories Co.,Ltd.

Immuno-Biological Laboratories Co.,Ltd.

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Aug 23Sep 11Sep 30Oct 19
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Immuno-Biological Laboratories Co.,Ltd. by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

53 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 22, 2026Barclays Capital Securities Ltd0.76%
October 21, 2026Barclays Capital Securities Ltd0.88%
October 19, 2026Barclays Capital Securities Ltd1.08%
October 15, 2026Barclays Capital Securities Ltd1.17%
October 13, 2026モルガン・スタンレーmufg証券株式会社0.49%
October 8, 2026Barclays Capital Securities Ltd1.36%
October 7, 2026Barclays Capital Securities Ltd1.23%
October 6, 2026Barclays Capital Securities Ltd1.02%
October 6, 2026モルガン・スタンレーmufg証券株式会社0.58%
October 2, 2026Barclays Capital Securities Ltd1.12%
October 1, 2026Barclays Capital Securities Ltd0.86%
October 1, 2026モルガン・スタンレーmufg証券株式会社0.67%
September 29, 2026Barclays Capital Securities Ltd0.75%
September 29, 2026モルガン・スタンレーmufg証券株式会社0.71%
September 28, 2026モルガン・スタンレーmufg証券株式会社0.67%
September 25, 2026Barclays Capital Securities Ltd0.66%
September 24, 2026モルガン・スタンレーmufg証券株式会社0.78%
September 18, 2026モルガン・スタンレーmufg証券株式会社0.91%
September 18, 2026Barclays Capital Securities Ltd0.50%
September 17, 2026モルガン・スタンレーmufg証券株式会社1.06%
September 17, 2026Barclays Capital Securities Ltd0.64%
September 16, 2026モルガン・スタンレーmufg証券株式会社1.12%
September 16, 2026Barclays Capital Securities Ltd0.80%
September 15, 2026モルガン・スタンレーmufg証券株式会社1.02%
September 14, 2026モルガン・スタンレーmufg証券株式会社0.94%
September 11, 2026モルガン・スタンレーmufg証券株式会社1.00%
September 11, 2026Barclays Capital Securities Ltd0.71%
September 9, 2026Barclays Capital Securities Ltd0.63%
September 8, 2026Barclays Capital Securities Ltd1.21%
September 8, 2026モルガン・スタンレーmufg証券株式会社0.93%
September 7, 2026Barclays Capital Securities Ltd1.05%
September 7, 2026モルガン・スタンレーmufg証券株式会社0.86%
September 3, 2026モルガン・スタンレーmufg証券株式会社0.94%
September 2, 2026Barclays Capital Securities Ltd1.16%
September 1, 2026モルガン・スタンレーmufg証券株式会社1.01%
September 1, 2026Barclays Capital Securities Ltd0.92%
August 31, 2026Barclays Capital Securities Ltd0.89%
August 28, 2026モルガン・スタンレーmufg証券株式会社0.90%
August 28, 2026Barclays Capital Securities Ltd0.75%
August 27, 2026モルガン・スタンレーmufg証券株式会社0.70%
August 26, 2026Barclays Capital Securities Ltd0.82%
August 26, 2026モルガン・スタンレーmufg証券株式会社0.53%
August 25, 2026Barclays Capital Securities Ltd0.76%
August 24, 2026Barclays Capital Securities Ltd0.82%
August 21, 2026Barclays Capital Securities Ltd0.72%
August 20, 2026Barclays Capital Securities Ltd0.64%
August 19, 2026Barclays Capital Securities Ltd0.58%
August 10, 2026モルガン・スタンレーmufg証券株式会社0.31%
August 10, 2026Nomura International plc0.00%
August 7, 2026モルガン・スタンレーmufg証券株式会社0.56%

Download 53 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Japan

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Immuno-Biological Laboratories Co.,Ltd., source JPX, data as at October 22, 2026, https://www.quivad.com/action/immuno-biological-laboratories-co-ltd